MA26341A1 - Stents - Google Patents

Stents

Info

Publication number
MA26341A1
MA26341A1 MA27648A MA27648A MA26341A1 MA 26341 A1 MA26341 A1 MA 26341A1 MA 27648 A MA27648 A MA 27648A MA 27648 A MA27648 A MA 27648A MA 26341 A1 MA26341 A1 MA 26341A1
Authority
MA
Morocco
Prior art keywords
stents
Prior art date
Application number
MA27648A
Other languages
English (en)
French (fr)
Inventor
Elisabeth Perzborn
Jochen Kalbe
Wolfram Ledwoch
Didier Meulien
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of MA26341A1 publication Critical patent/MA26341A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/04—Use of organic materials, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA27648A 2001-10-24 2004-04-23 Stents MA26341A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10152460A DE10152460A1 (de) 2001-10-24 2001-10-24 Stents

Publications (1)

Publication Number Publication Date
MA26341A1 true MA26341A1 (fr) 2004-10-01

Family

ID=7703557

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27648A MA26341A1 (fr) 2001-10-24 2004-04-23 Stents

Country Status (22)

Country Link
US (1) US20050064006A1 (cg-RX-API-DMAC7.html)
EP (1) EP1439869A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005506151A (cg-RX-API-DMAC7.html)
KR (1) KR20040074977A (cg-RX-API-DMAC7.html)
CN (1) CN1575189A (cg-RX-API-DMAC7.html)
AU (1) AU2002340549B2 (cg-RX-API-DMAC7.html)
BR (1) BR0213481A (cg-RX-API-DMAC7.html)
CA (1) CA2464290A1 (cg-RX-API-DMAC7.html)
DE (1) DE10152460A1 (cg-RX-API-DMAC7.html)
EC (1) ECSP045075A (cg-RX-API-DMAC7.html)
EE (1) EE200400080A (cg-RX-API-DMAC7.html)
HR (1) HRP20040456A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0401760A3 (cg-RX-API-DMAC7.html)
IL (1) IL161445A0 (cg-RX-API-DMAC7.html)
MA (1) MA26341A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04003755A (cg-RX-API-DMAC7.html)
NO (1) NO20041984L (cg-RX-API-DMAC7.html)
NZ (1) NZ532443A (cg-RX-API-DMAC7.html)
PL (1) PL367968A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004115757A (cg-RX-API-DMAC7.html)
WO (1) WO2003035133A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200402989B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10129725A1 (de) * 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
DE10355461A1 (de) * 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
WO2007039132A1 (de) 2005-10-04 2007-04-12 Bayer Healthcare Ag Neue polymorphe form und die amorphe form von 5-chlor-n- ( { ( 5s ) -2-0x0-3-[4-( 3-oxo-4-morpholinyl) - phenyl] -1,3-oxazolidin-5-yl} -methyl) -2- thiophencarboxamid
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
US20070097252A1 (en) * 2005-10-31 2007-05-03 Silverstein D A Imaging methods, cameras, projectors, and articles of manufacture
DE102006034916A1 (de) * 2006-07-28 2008-01-31 Bayer Healthcare Ag Beschichtung künstlicher Oberflächen von medizinischen Hilfsmitteln und Geräten sowie Reinigung und/oder Vorbehandlung von Kathetern und anderen medizinischen Hilfsmitteln und Geräten
DE102006051625A1 (de) * 2006-11-02 2008-05-08 Bayer Materialscience Ag Kombinationstherapie substituierter Oxazolidinone
WO2009063028A2 (en) * 2007-11-15 2009-05-22 Boehringer Ingelheim International Gmbh Substituted amides, manufacturing and use thereof as medicaments
US11654036B2 (en) 2020-05-26 2023-05-23 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use
WO2021242783A1 (en) * 2020-05-26 2021-12-02 Elixir Medical Corporation Anticoagulant compounds and methods and devices for their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
US6133256A (en) * 1997-04-14 2000-10-17 Cor Therapeutics Inc Selective factor Xa inhibitors
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US20010029351A1 (en) * 1998-04-16 2001-10-11 Robert Falotico Drug combinations and delivery devices for the prevention and treatment of vascular disease
DE19962924A1 (de) * 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
DE10105989A1 (de) * 2001-02-09 2002-08-14 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung

Also Published As

Publication number Publication date
ECSP045075A (es) 2004-05-28
US20050064006A1 (en) 2005-03-24
AU2002340549B2 (en) 2007-11-29
ZA200402989B (en) 2005-04-20
IL161445A0 (en) 2004-09-27
MXPA04003755A (es) 2004-07-23
EE200400080A (et) 2004-08-16
CN1575189A (zh) 2005-02-02
CA2464290A1 (en) 2003-05-01
PL367968A1 (en) 2005-03-07
BR0213481A (pt) 2004-11-03
EP1439869A1 (de) 2004-07-28
KR20040074977A (ko) 2004-08-26
NO20041984L (no) 2004-05-13
JP2005506151A (ja) 2005-03-03
HUP0401760A3 (en) 2008-04-28
NZ532443A (en) 2005-11-25
WO2003035133A1 (de) 2003-05-01
DE10152460A1 (de) 2003-05-08
HRP20040456A2 (en) 2005-06-30
RU2004115757A (ru) 2005-04-10
HUP0401760A2 (hu) 2004-12-28

Similar Documents

Publication Publication Date Title
DE50112209D1 (de) Stent
DE60236093D1 (de) Entfernbarer stent
LU92359I2 (fr) Lipegfilgrastim
EE200100132A (xx) Stent
EE200100304A (xx) Stent
DE60227511D1 (de) Umzeitkodierung
ATE524462T1 (de) C5-modifizierte indazolylpyrrolotriazine
FI20010694L (fi) Implantti
DE50103741D1 (de) Welle-Nabe-Verbindung
DE60208317D1 (de) Ozonisator
ATE335486T1 (de) Hydrazono-malonitrile
NO20041984L (no) Stenter
DE50203412D1 (de) Schwenkkolbenverdränger
DE60220342D1 (de) Reifenlaufflächdüse
ATE355059T1 (de) Isoxazolopyridinone
DE50201862D1 (de) Messwandler
NO20025846L (no) Mikrobölgekrets
DE50203093D1 (de) Losradlager
ATA18372001A (de) Gelenksbolzenbaueinheit
DE60234854D1 (de) Genüberexpressionssystem
ATE319694T1 (de) Phenylalkyne
DE50202088D1 (de) Garmodulsystem
ATA13992002A (de) Schlackengranulierungsanlage
FR2825911B1 (fr) Implant cotyloidien
DE50201746D1 (de) Prothese